Latest News of BIIB
Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
By Yahoo! Finance |
2 weeks ago
A list of top genomics stocks includes Biogen Inc. (NASDAQ:BIIB). Genomics sector is rapidly growing due to technological advancements reducing costs and time to map genomes. Investors like Cathie Woo...
Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
By Yahoo! Finance |
2 weeks ago
Analysts debate a third year of the NASDAQ bull market. Data suggests a positive outlook, with room for growth. Biogen Inc. (NASDAQ:BIIB) stands out as a promising, undervalued stock. Hedge fund strat...
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now
By Yahoo! Finance |
1 month ago
A list of oversold large cap stocks includes Biogen Inc. The recent Fed rate cuts and market performance suggest optimism. Noah Blackstein's positive outlook on equity markets emphasizes the need for ...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts?
By Yahoo! Finance | 1 month agoAn analysis of the best QQQ stocks to buy includes Biogen Inc. The Fed's rate cuts impact the market positively, with strong economic growth. Quality stocks are essential in the current uncertain clim...
-
Biogen Inc. (BIIB): Worst Performing NASDAQ Stock in 2024
By Yahoo! Finance | 1 month agoThe article discusses the poor performance of Biogen Inc. (NASDAQ:BIIB) in 2024 compared to other NASDAQ stocks. Factors impacting stock market momentum include AI, earnings, interest rates, and geopo...
-
Biogen Inc. (BIIB): Among the Best Bargain Stocks to Buy In October
By Yahoo! Finance | 2 months agoA list of 8 Best Bargain Stocks to buy in October was compiled, including Biogen Inc. (NASDAQ:BIIB). Analysts discuss market outlook pre-election and post-easing cycle, suggesting a potential rally in...
-
Results: Biogen Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
By Yahoo! Finance | 3 months agoBiogen Inc. reported strong Q2 earnings, surpassing revenue expectations and showing a 13% increase in EPS. Analysts predict a positive outlook for 2024, with revenue staying steady and EPS rising. De...
-
Is Biogen (BIIB) an Underappreciated Stock?
By Yahoo! Finance | 4 months agoPatient Capital Management released its Q2 2024 investor letter for their "Patient Capital Opportunity Equity Strategy," reporting a -1.9% return compared to the S&P 500's 4.3% gain. Biogen Inc....
-
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
By Yahoo! Finance | 5 months agoClearBridge Investments outperformed the Russell 1000 Value Index in Q1 2024. The ClearBridge Value Equity Strategy showed gains in most sectors, with top contributors in financial and utilities. Biog...
-
Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 5 months agoLeqembi is the first Alzheimer's treatment that alters the disease's course by removing toxic beta amyloid protein from the brain. Eisai plans to offer partial drug cost coverage in collaboration with...